Characterization of a mouse model of ICF syndrome reveals enhanced CD19 activation in inducing hypogammaglobulinemia
Z. Ying, S. Hardikar, J. B. Plummer, T. Hamidi, B. Liu, Y. Chen, J. Shen, Y. Mu, K. M. McBride, T. Chen
This study characterizes a mouse model of ICF syndrome, revealing that Zbtb24 deficiency leads to hypogammaglobulinemia via enhanced CD19 activation and IL-5 signaling.
bioRxiv · Mar 9, 2023Immunology